Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07044765
PHASE1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Sponsor: AJU Pharm Co., Ltd.

View on ClinicalTrials.gov

Summary

To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults after taking the drugs with food (fed state).

Official title: An Open-label, 2-arm, Single-sequence, Fed, Single Oral Dosing, Crossover Clinical Trial to Evaluate Safety and the Pharmacokinetics Between Dapagliflozin, Linagliptin and Metformin in Healthy Adult Subjects

Key Details

Gender

All

Age Range

19 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2025-08

Completion Date

2025-11

Last Updated

2025-07-01

Healthy Volunteers

Yes

Interventions

DRUG

Comparator 1

Dapagliflozin 10mg + Linagliptin 5mg

DRUG

Comparator 2

Metformin 1000mg

DRUG

Test Drug

Fixed-dose combination tablet (AJU-A53)

Locations (1)

Chung-Ang University Gwangmyeong Hospital

Gwangmyeong, Gyeonggi-do, South Korea